Selectively inhibiting FTO by inhibitors decreases FOXO1 expression and reduces body weight and fat mass in a high-fat diet-induced obesity (DIO) mouse model. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.